CGTX
NASDAQ · Pharmaceuticals
Cognition Therapeutics Inc
$1.07
-0.01 (-0.93%)
Open$1.08
Previous Close$1.08
Day High$1.12
Day Low$1.05
52W High$3.83
52W Low$0.22
Volume—
Avg Volume677.9K
Market Cap95.34M
P/E Ratio—
EPS$-0.48
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+2,793.5% upside
Current
$1.07
$1.07
Target
$30.96
$30.96
$22.83
$30.96 avg
$36.58
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 14.30M | 12.78M | 15.45M |
| Net Income | 4.19M | 3.83M | 4.28M |
| Profit Margin | 29.3% | 30.0% | 27.7% |
| EBITDA | 6.72M | 5.55M | 6.77M |
| Free Cash Flow | 3.42M | 2.69M | 4.56M |
| Rev Growth | -4.2% | +12.1% | -7.5% |
| Debt/Equity | 0.88 | 0.74 | 0.77 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |